180 Wealth Advisors’s Viking Therapeutics VKTX Stock Holding History

180 Wealth Advisors’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$341K	Buy	+8,753	New	+$283K	0.03%	364
2026 Q1	–	Sell	-5,807	Closed	-$204K	–	496
2025 Q4	$204K	Buy	+5,807	New	+$206K	0.02%	446
2024 Q1	–	Sell	-10,000	Closed	-$183K	–	421
2023 Q4	$183K	Sell	10,000 -3,000	-23%	-$39.2K	0.04%	360
2023 Q3	$144K	Hold	13,000	–	–	0.03%	349
2023 Q2	$201K	Sell	13,000 -1,000	-7%	-$21K	0.04%	334
2023 Q1	$233K	Sell	14,000 -6,300	-31%	-$65.1K	0.05%	306
2022 Q4	$171K	Buy	20,300 +300	+2%	+$1.34K	0.04%	341
2022 Q3	$54K	Buy	20,000 +3,000	+18%	+$9.83K	0.01%	352
2022 Q2	$48K	Buy	+17,000	New	+$42.1K	0.01%	364

Other funds holding VKTX

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

RFM

Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

HCA

Harbour Capital Advisors Tysons Corner, Virginia $549M AUM 54.99% 1-Year Est. Return

180 Wealth Advisors's VKTX Position: Q2 2026 in Review

180 Wealth Advisors opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 8,753 shares worth $341K. The stake represents 0.03% of the portfolio and ranks #364 among its holdings. This is a return to the name: 180 Wealth Advisors previously reported a position in VKTX as recently as Q4 2025.

180 Wealth Advisors first reported a position in VKTX in Q2 2022 and has held it in 9 quarters since. 39 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

180 Wealth Advisors held 8,753 shares of Viking Therapeutics worth $341K as of Q2 2026.
Viking Therapeutics was a new 180 Wealth Advisors position in Q2 2026.
Viking Therapeutics made up 0.03% of 180 Wealth Advisors's portfolio in Q2 2026, its #364 holding.
180 Wealth Advisors first reported a position in Viking Therapeutics in Q2 2022 and has held it in 9 quarters since.
39 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on 180 Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.